TABLE 3

Inhibition of 1,25(OH)2D3 mono-hydroxylation activity of CYP3A4, liver microsomes, intestinal homogenate, and CYP24A1 by TAO and ketoconazole (KTZ)

TAO (20 μM) was preincubated with the source enzyme and NADPH for 15 min before a 20-μl aliquot (containing the appropriate amount of source enzyme) was then transferred to the final incubation tube. Ketoconazole (100 nM) was added directly to the incubation mixture before addition of NADPH.

Recombinant CYP3A4 Liver Microsomes Intestinal Homogenate Recombinant CYP24A1
% of control
TAO (20 μM) 12 ± 1 15 ± 1 16 ± 1 102 ± 7
KTZ (100 nM) 2 ± 1 2 ± 1 2 ± 1 95 ± 1a
  • a Ketoconazole at 1 μM also showed no inhibition toward CYP24A1 activity.